The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

Gastroenterology

Volumn 116, Issue 2, 1999, Pages 248-253

  Lind, T ^a   Megraud, F ^a   Unge, P ^a   Bayerdorffer, E ^a   O'Morain, C ^a   Spiller, R ^a   Van Zanten, S V ^a   Dev Bardhan, K ^a   Hellblom, M ^a   Wrangstadh, M ^a   Zeijlon, L ^a   Cederberg, C ^a  

^a Karnsjukhuset   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; DUODENUM ULCER; FEMALE; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFECTION CONTROL; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

EID: 0032958703     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70119-8     Document Type: Article

References (15)

1. T Lind S Veldhuyzen van Zanten P Unge R Spiller E Bayerdörffer C O'Morain KD Bardhan M Bradette N Chiba M Wrangstadh C Cederberg J-P. Idström Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH1 study Helicobacter 1 1996 138 144
2. F. Mégraud Rationale for the choice of antibiotics for eradication of Helicobacter pylori Eur J Gastroenterol Hepatol 7 suppl 1 1995 S49 S54
3. Y Glupczynski Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing A Lee Mégraud F Helicobacter pylori: techniques for clinical diagnosis & basic research. 1996 Saunders Philadelphia 17 32
4. DY Graham A de Boer Wink GNJ. Tytgat Choosing the best anti- Helicobacter pylori therapy: effect of antimicrobial resistance Am J Gastroenterol 91 1996 1072 1075
5. ML Grayson GM Eliopoulos MJ Ferraro RC Moellering Jr. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents Eur J Clin Microbiol Infect Dis 8 1989 888 889
6. L Laine JE Frantz A Baker G. Neil A United States multicentre trial of dual and proton pump inhibitor based triple therapies for Helicobacter pylori Aliment Pharmacol Ther 11 1997 913 917
7. AF Goddard MJ Jessa DA Barrett PN Shaw JP Idstrom C Cederberg RC. Spiller Effect of omeprazole on the distribution of metronidazole, amoxycillin and clarithromycin in human gastric juice Gastroenterology 111 1996 358 367
8. PO Erah AF Goddard DA Barrett PN Shaw RC. Spiller The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection J Antimicrob Chemother 37 1997 5 12
9. P Unge A Gad H Gnarpe J. Olsson Does omeprazole (40 mg o.m.) improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? Scand J Gastroenterol 24 suppl 167 1989 49 54
10. SJ Veldhuyzen van Zanten PT Pollak H Kapoor PK. Yeung Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori Dig Dis Sci 41 1996 1845 1852
11. JM Buckley H-I Xia DM Hyde CT Keane C. O'Morain Metronidazole resistance reduces the efficacy of triple therapy and leads to secondary clarithromycin resistance Dig Dis Sci 1998 (in press)
12. P Moayyedi P Sahay DS Tompkins AT. Axon Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori Eur J Gastroenterol Hepatol 7 1995 835 840
13. GD Bell KU Powell SM Burridge AF Bowden W Atoyebi GH Bolton PH Jones C. Brown Rapid eradication of Helicobacter pylori infection Aliment Pharmacol Ther 9 1995 41 46
14. J Labenz JA Beker CP Dekker A Farley HU Klor A. Jonsson Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients Aliment Pharmacol Ther 11 1997 515 522
15. Current European concepts in the management of Helicobacter pylori infection—the Maastricht consensus report Gut 41 1997 8 13